# MBX: Advancing once-weekly and once-monthly peptide therapies with strong clinical and market momentum - TradingView

*Источник: TradingView*
*Дата: 2026-09-30*
*Язык: en*

**Кратко:** MBX: Advancing once-weekly and once-monthly peptide therapies with strong clinical and market momentum
The forum highlighted a robust pipeline in rare endocrinology and obesity, with phase III for canvuparatide underway and promising early data for once-monthly obesity therapies. The platform's unique PK profiles and multi-mechanism molecules aim to address unmet needs and market segments.

MBX: Advancing once-weekly and once-monthly peptide therapies with strong clinical and market momentum
The forum highlighted a robust pipeline in rare endocrinology and obesity, with phase III for canvuparatide underway and promising early data for once-monthly obesity therapies. The platform's unique PK profiles and multi-mechanism molecules aim to address unmet needs and market segments.

[Оригинал](https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:4213562:0-mbx-advancing-once-weekly-and-once-monthly-peptide-therapies-with-strong-clinical-and-market-momentum/)